Cart
sales@molnova.com
Marimastat
CAS No. 154039-60-8
Marimastat( BB-2516 | TA-2516 )
Catalog No. M12177 CAS No. 154039-60-8
A broad spectrum MMP inhibitor for MMP9/1/2/14/7 with IC50 of 3/5/6/9/13 nM, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 58 | In Stock |
|
| 5MG | 81 | In Stock |
|
| 10MG | 123 | In Stock |
|
| 25MG | 218 | In Stock |
|
| 50MG | 355 | In Stock |
|
| 100MG | 523 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMarimastat
-
NoteResearch use only, not for human use.
-
Brief DescriptionA broad spectrum MMP inhibitor for MMP9/1/2/14/7 with IC50 of 3/5/6/9/13 nM, respectively.
-
DescriptionA broad spectrum MMP inhibitor for MMP9/1/2/14/7 with IC50 of 3/5/6/9/13 nM, respectively.Lung Cancer Phase 3 Clinical(In Vitro):Marimastat (BB2516) (1 μM) shows inhibition of vascular outgrowth, and selectively affects angiogenesis.(In Vivo):Animals receiving chemoradiation + Marimastat (BB2516) (8.7 mg/kg) have statistically significant delayed growth, compared to animals receiving chemoradiation alone. Marimastat (BB2516) may work in combination with chemotherapy and radiation to inhibit tumor growth.
-
In Vitro——
-
In Vivo——
-
SynonymsBB-2516 | TA-2516
-
PathwayMetabolic Enzyme/Protease
-
TargetMMP
-
RecptorMMP-1| MMP-14| MMP-2| MMP-7| MMP-9
-
Research AreaCancer
-
IndicationLung Cancer
Chemical Information
-
CAS Number154039-60-8
-
Formula Weight331.4079
-
Molecular FormulaC15H29N3O5
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 140 mg/mL
-
SMILESO=C(N[C@@H](C(C)(C)C)C(NC)=O)[C@H](CC(C)C)[C@H](O)C(NO)=O
-
Chemical NameButanediamide, N4-[(1S)-2,2-dimethyl-1-[(methylamino)carbonyl]propyl]-N1,2-dihydroxy-3-(2-methylpropyl)-, (2S,3R)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Rasmussen HS, et al. Pharmacol Ther. 1997;75(1):69-75.
2. Sinno M, et al. Stem Cells Dev. 2013 Feb 1;22(3):345-58.
3. Quemener C, et al. Cancer Res. 2007 Jan 1;67(1):9-15.
molnova catalog
related products
-
BPHA
BPHA (MMP-2/MMP-9 Inhibitor II) is a potent, selective and orally active inhibitor of MMP-2, MMP-9 and MMP-14 with IC50s of 12 nM, 16 nM and 17 nM, respectively.
-
GI 254023X
GI254023X is a potent MMP9 and ADAM10 inhibitor (IC50s: 2.5 and 5.3 nM) with 100-fold selectivity for the α-secretase ADAM10 over ADAM17 (TACE).
-
Fenofibric acid
Fenofibric acid is a lipid regulating agent available as delayed release capsules for oral administration.
